Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Evolus Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Tenaya Therapeutics Inc. May 27, 202695.5%
-
Evolus Inc. June 6, 20240.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 3, 2026 | Ultragenyx Pharmaceutical Inc. | Open-market sale | −1,900 | $24.92 | $47,348 |
| Jun 15, 2026 | Ultragenyx Pharmaceutical Inc. | Open-market sale | −1,899 | $24.62 | $46,753 |
| Apr 16, 2026 | Ultragenyx Pharmaceutical Inc. | Grant or award | +28,895 | — | — |
| Mar 10, 2026 | Ultragenyx Pharmaceutical Inc. | Open-market sale | −3,508 | $22.67 | $79,526 |
| Mar 6, 2026 | Ultragenyx Pharmaceutical Inc. | Open-market sale | −6,018 | $21.40 | $128,785 |
| Mar 2, 2026 | Ultragenyx Pharmaceutical Inc. | Open-market sale | −8,135 | $22.80 | $185,478 |
| Mar 1, 2026 | Ultragenyx Pharmaceutical Inc. | Grant or award | +11,137 | — | — |
| Feb 17, 2026 | Evolus Inc. | Grant or award | +45,559 | — | — |
| Sep 12, 2025 | Ultragenyx Pharmaceutical Inc. | Open-market sale | −2,450 | $31.17 | $76,367 |
| Mar 12, 2025 | Evolus Inc. | Open-market sale | −12,888 | $12.99 | $167,415 |
| Mar 7, 2025 | Evolus Inc. | Grant or award | +7,364 | — | — |
| Mar 3, 2025 | Ultragenyx Pharmaceutical Inc. | Open-market sale | −12,846 | $42.10 | $540,817 |
| Mar 1, 2025 | Ultragenyx Pharmaceutical Inc. | Grant or award | +18,443 | — | — |
| Mar 1, 2025 | Ultragenyx Pharmaceutical Inc. | Grant or award | +14,494 | — | — |
| Feb 27, 2025 | Ultragenyx Pharmaceutical Inc. | Open-market sale | −2,230 | $42.93 | $95,734 |
Questions about Karah Herdman Parschauer
What boards is Karah Herdman Parschauer on?
Karah Herdman Parschauer sits on the boards of Evolus Inc. and Tenaya Therapeutics Inc.
How long has Karah Herdman Parschauer served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.